IBDPal Executive Summary - Funding Request

Executive Summary

IBDPal is a comprehensive iOS application and web platform designed to revolutionize the management of Inflammatory Bowel Disease (IBD) and Crohn disease through advanced nutrition tracking, AI-powered flare risk assessment, and personalized patient care. Developed by MediVue, a 501(c)(3) nonprofit organization registered in North Carolina, IBDPal addresses the critical gap in specialized healthcare technology for the 3.1 million Americans living with IBD.

Market Opportunity
3.1M
Americans with IBD
$31B
Annual Healthcare Costs
70%
Experience Flares
$2.5B
Digital Health Market

Problem Statement

Current IBD management lacks personalized, data-driven approaches. Patients struggle with:

Nutritional Deficiencies: 60-80% of IBD patients experience malnutrition
Flare Prediction: No reliable early warning system for disease exacerbations
Fragmented Care: Disconnected tracking of symptoms, diet, and medications
Limited Research Integration: Lack of evidence-based nutrition guidelines
Isolation: Limited peer support and community connection

Solution & Technology

IBDPal provides a comprehensive ecosystem combining iOS mobile app, web platform, and AI-powered backend:

iOS Application

SwiftUI, Core Data, Charts, Combine

Backend Infrastructure

Node.js, Express, PostgreSQL, JWT Security

AI & Analytics

Machine Learning, Trend Analysis, Flare Prediction

Core Features:

Daily Logging: Comprehensive tracking of meals, symptoms, medications, and bowel health
AI-Powered Flare Risk Assessment: 3-month trend analysis with early warning system
Research-Based Nutrition Analysis: FODMAP, IBD, and Crohn-specific benchmarks
Micronutrient Management: Deficiency identification and personalized recommendations
Community Platform: IBD Stories for peer support and success sharing
Smart Search & Discovery: AI-powered insights and trend visualization

Market Validation & Traction

Clinical Evidence & Research Foundation
Built on peer-reviewed IBD and Crohn disease research
FODMAP diet integration for symptom management
Evidence-based nutrition benchmarks and guidelines
Correlation algorithms linking diet, symptoms, and flare risk

Target Market Segments:

Primary: IBD patients (Crohn disease, Ulcerative Colitis) - 3.1M Americans
Secondary: Healthcare providers, nutritionists, gastroenterologists
Tertiary: Caregivers, family members, support groups

Business Model & Revenue Streams

Freemium

Basic Tracking

Premium

AI Analytics

B2B

Healthcare Providers

Research

Data Partnerships

Subscription Model: Premium features for advanced analytics and AI insights
Healthcare Partnerships: B2B licensing to hospitals and clinics
Research Collaborations: Anonymized data partnerships with medical institutions
Pharmaceutical Partnerships: Clinical trial support and patient engagement

Funding Requirements & Use of Funds

Seeking: $500,000 - $750,000 Series A Funding
40% - Product Development: iOS app completion, web platform, AI algorithms
25% - Clinical Validation: Pilot studies, FDA pathway, medical partnerships
20% - Marketing & User Acquisition: App Store optimization, healthcare marketing
10% - Operations: Infrastructure, security, compliance
5% - Legal & IP: Patent filings, regulatory compliance

Competitive Advantage

Specialized Focus: Only comprehensive IBD-specific platform with AI flare prediction
Research Integration: Built on peer-reviewed medical research and clinical guidelines
Nonprofit Mission: Patient-first approach without profit-driven limitations
Technical Excellence: Modern iOS architecture with scalable backend infrastructure
Community Building: Integrated peer support and success story sharing

Team & Organization

MediVue is a 501(c)(3) nonprofit organization dedicated to improving healthcare outcomes for IBD patients through innovative technology solutions. Our mission-driven approach ensures patient welfare remains the primary focus while building sustainable, scalable solutions for the healthcare community.

Contact Information

Organization: MediVue (501(c)(3) Nonprofit)

Website: ibdpal.org

Email: info@ibdpal.org | contactus@ibdpal.org

Registered: State of North Carolina